RecruitingNCT01720810

Pacific Northwest Udall Center (PANUC) Clinical Core

Sponsor

University of Washington

Enrollment

2,000 participants

Start Date

Mar 1, 2010

Study Type

OBSERVATIONAL

Conditions

Cognitive Impairment Parkinson Disease

Summary

This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study, part of the Pacific Northwest Udall Center, collects health and research data from people with Parkinson's disease to better understand the condition and how it progresses over time. **You may be eligible if...** - You have been diagnosed with Parkinson's disease - You are 18 years of age or older **You may NOT be eligible if...** - You are under 18 years of age Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

VA Puget Sound Health Care System

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01720810

Related Trials

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

NCT0523075820 locations

The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

NCT034574931 location